Physician profile
Rohit Ranganath
NPI 1700147360
$12,376.29
in general payments reported to CMS, 2019-2025
12 companies · $627 in 2025
The $627 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $866 · 2020: $10K · 2022: $106 · 2023: $215 · 2024: $408 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,018.73 | 2019-2020 | |
| Medtronic, INC. | $477.63 | 2023-2025 | Pteye Parathyroid Detection System, Signet, Ligasure |
| Inspire Medical Systems, INC. | $475.02 | 2024-2025 | Inspire |
| Polynovo North America LLC | $61.83 | 2022-2023 | |
| Checkpoint Surgical, INC | $61.56 | 2025 | Checkpoint Stimulators |
| Tactile Systems Technology INC | $52.24 | 2023 | Flexitouch Plus, Entre Plus |
| Cumberland Pharmaceuticals, INC. | $51.32 | 2022-2023 | Caldolor |
| Hologic Sales and Service, LLC | $51.00 | 2023-2024 | Trident Specimen Radiography System, Localizer, Coolseal Generator |
| Stryker Corporation | $48.67 | 2023 | Spy-Phi System |
| Janssen Pharmaceuticals, INC | $35.00 | 2023-2024 | Xarelto |
| Integra Lifesciences Corporation | $22.96 | 2022 | |
| Merck Sharp & Dohme LLC | $20.33 | 2025 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Ranganath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.